Menu

NextCure, Inc. NXTC

Full chart Compare
Set alert

Price alert · NXTC

All alert types
5.11 USD 0.00 (+0.00%)

Nov 6, 2026, 12:48 PM EST

5.10 Day range 5.71
1.55 52-week range 15.74
YTD
-63.99%
1 year
-47.96%

Revenue & Expenses

Other Income → Expenses: $4.62MExpenses → Selling, General & Admin: $17.05MExpenses → Research & Development: $46.55MGross Profit → Expenses: $22.38MRevenue → Gross Profit: $22.38MNet Loss → Expenses: $36.60MOther Income$4.62MGross Profit$22.38MNet Loss$36.60MExpenses$63.60MSelling, General & Admin$17.05MResearch & Development$46.55MRevenue$22.38M

Latest period ending Dec 31, 2025 · select a line to chart its full history

NXTC annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-57.62M-59.75M-67.64M-75.91M-70.77M
-55.84M-55.65M-62.72M-74.73M-69.39M
-19.65-23.88-27.00-32.30-30.10
NXTC annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
25.98M27.73M13.08M26.63M12.34M
50.18M80.86M128.04M184.16M242.39M
15.24M15.39M13.62M16.63M9.00M
4.15M5.15M5.95M6.61M0
34.94M65.47M114.42M167.53M233.39M
NXTC annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-49.61M-40.80M-52.97M-53.89M-57.28M
25.56M55.31M39.27M67.98M36.60M
22.31M144.00K154.00K200.00K-3.27M
-1.75M14.64M-13.55M14.29M-23.95M